Olink

Olink®
Part of Thermo Fisher Scientific

Clarity in complexity

Olink® Target 48 Neurodegeneration

Absolute quantification. Key markers. Profound insights

There is a critical need for a tool that enables the detection of key neurodegenerative disease biomarkers from plasma samples to enhance analysis of patient material within clinical trials. A high-performance absolute quantification solution is urgently required to ensure precise, reliable, and reproducible results across and within longitudinal studies.

Inside Target 48 Neurodegeneration Panel

Join the September 17 live event for the first look at data and the complete set of assays in the Target 48 Neurodegeneration Panel.

Register now

Coming soon – Target 48 Neurodegeneration panel

Overview

  • Proteins*

    42 1 Panel

  • Samples

    40 per Kit

  • Sample volume

    1 µL per panel

  • Readout

    pg/mL Absolute units

  • Runs on

    Signature Q100

    Learn more

*anticipated in the final product

Absolute quantification

Gain previously inaccessible insights that drive clinical translation.

Learn more

Key markers

Confidently track key neurodegeneration biomarkers—All-in-one panel.

Learn more

Profound Insights

Dive into disease complexity with mechanistic breadth.

Learn more

Ready to take the next step?

Contact us to discover more and preorder your kit.

Contact us

Absolute quantification

Compare across cohorts, time points, and studies, empowered by precise absolute quantification. Generate rich, robust data from just a few microlitres of plasma or CSF, maximizing the value of each precious sample.

Monitor longitudinal changes

Comparisons across timepoints of sample collection within a study or clinical trial.

Identify distinct profiles across projects

Comparisons between neurodegenerative diseases, disease subtypes, stages or treatments within the same institute.

Collaborate and compare across sites

Comparison of data generated by different laboratories, either within the same project or across separate studies.

Key markers

Quantify pTau217, Aβ40, Aβ42, NfL, GFAP, and more in a single, scalable assay—saving time, cost, and precious patient sample.

Alzheimer’s Disease and other dementia

pTau217, Aß40, Aß42, GFAP, NFL, NPTX2, BACE1, MMP10 and more.

Multiple Sclerosis

MOG, OMG, NGF, NFL, GFAP and more.

Parkinson’s Disease

DDC, SNCAIP, SCG2, LRRK2, GLRX and more.

Profound insights

Uncover disease-driving biology with biomarker content purposefully curated by global experts and biobank data, spanning synaptic proteins, neuroinflammation, clearance, and beyond.

Neurodegeneration

Aß40, Aß42, pTau217, NEFL, WWOX, MOG, OMG,  BMP7, EIF2AK2.

Synaptic function

NPTXR, NPTX1, NPTX2, CLSTN3, GLRX, NLGN1, STX1B, SYT1.

Clearance

DDHA1, BACE1, ENO2, KLK8, TP53, SCG2.

Neuroinflammation

GFAP, S100B, AGER, HLA-DRA, MMP10.

Elevate your immunoassay experience

Beyond the Olink panel lies a wide range of free tools for study design, statistical analysis, data visualization and quality control. There’s also continuous support from our data science experts and customer service teams. We’re proud to be active partners to thousands of researchers, from small lab teams to major institutions and consortia.

Absolute quantification

Quantify your samples with ultimate precision, use your reagents efficiently, and minimize hands-on time and variability.

Download

Streamlined workflow

Focus your time and effort on your research instead of washing steps and hands-on instrument handling. Use NPX Signature for QC and to generate analysis reports.